We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1776:HKEXHeadway Advanced Materials Inc. Analysis

Data as of 2026-05-18 - not real-time

NT$18.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Headway Advanced Materials is trading at TWD 18.1, comfortably above its 20‑day SMA (16.99) and the 50‑day SMA (16.23), indicating a short‑term bullish bias. Technical signals such as a bullish MACD crossover, RSI at 62, and increasing volume reinforce this momentum, while the price sits near the identified support of 15.95 and well below the resistance at 20.55.
Fundamentally, the stock appears significantly undervalued against its discounted cash‑flow estimate of TWD 47.3, yet it suffers from a 21% revenue decline, thin gross margin (17.3%) and a modest profit margin (1.6%). The high trailing PE of 69 versus a forward PE of 14 suggests earnings are expected to improve, but the payout ratio of nearly 300% raises doubts about dividend sustainability.
Given a low beta of 0.24 but high 30‑day volatility (~40%), the equity carries modest market risk but heightened price swings. Geopolitical exposure in Taiwan and the chemical‑industry regulatory environment add medium‑level sector and geographic risks, while the current dividend yield of 3.16% may be attractive only if the payout can be trimmed.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup (price above SMA20/50, bullish MACD, RSI 62)
  • Significant valuation gap to DCF fair value
  • Increasing trading volume supporting momentum

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued price relative to fundamentals
  • Weak revenue growth and thin margins
  • High dividend payout ratio questioning sustainability

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Continued revenue contraction and modest profitability
  • Potential dividend cuts due to unsustainable payout
  • Geopolitical and regulatory exposure in the chemicals sector

Key Metrics & Analysis

Financial Health

Revenue Growth-21.20%
Profit Margin1.60%
P/E Ratio69.6
ROE1.36%
ROA1.38%
Debt/Equity34.30
P/B Ratio1.3
Op. Cash FlowNT$183.6M
Free Cash FlowNT$197.9M

Technical Analysis

TrendBullish
RSI62.6
SupportNT$15.95
ResistanceNT$20.55
MA 20NT$17.00
MA 50NT$16.23
MA 200NT$15.55
MACDBullish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair ValueNT$47.30
GradeUndervalued
TypeValue
Dividend Yield3.16%

Risk Assessment

Beta0.24
Volatility39.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.